Literature DB >> 27373212

Targeting of MCT1 and PFKFB3 influences cell proliferation and apoptosis in bladder cancer by altering the tumor microenvironment.

Ke Yao Hu1, De Gui Wang2, Peng Fei Liu1, Yan Wei Cao1, Yong Hua Wang1, Xue Cheng Yang1, Cheng Xia Hu3, Li Jiang Sun1, Hai Tao Niu1.   

Abstract

Phosphofructokinase-2/fructose-2,6-bisphosphatase 3 (PFKFB3) and monocarboxylate transporter 1 (MCT1) play important roles in tumor endothelial cells (ECs) and several biological processes. The present study was conducted to study the effects of PFKFB3 and MCT1 on cell proliferation and apoptosis in the tumor microenvironment by co-culture of HUVECs and T24, a bladder cancer (BC) cell line, using a microfluidic device. Immunofluorescence assay showed that HUVEC activity was significantly enhanced under co-culture with T24 cells, according to the stronger fluorescence intensity of CD31 and CD105 than that in the signal‑cultured cells. Quercetin treatment inhibited MCT1 expression but did not affect PFKFB3 expression. Knockdown of MCT1 or/and PFKFB3 increased the apoptosis rate of the HUVECs under single-culture and co-culture situations by staining with calcein and propidium iodide. Meanwhile, cell proliferation and lactic concentration were significantly decreased after the blocking of MCT1 or/and PFKFB3, as compared with that in the control group. No obvious differences in the effects on apoptosis, proliferation and lactic concentration were found between cells treated with quercetin and siMCT1. Thus, we concluded that the targeting of MCT1 and PFKFB3 regulated cell proliferation and apoptosis in BC cells by altering the tumor microenvironment, and quercetin exhibited a potential antitumor effect by targeting MCT1.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27373212     DOI: 10.3892/or.2016.4884

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  [Small interfering RNA-mediated monocarboxylate transporter 1 silencing enhances sensitivity of nasopharyngeal carcinoma HNE1/DDP cells to cisplatin-induced apoptosis].

Authors:  Pei Zhang; Fang Liu; Jiao Gao; Lin-Yan Ma; Xiao-Jin Sun; Hai-Lun Zheng; Hao Liu; Su-Rong Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

2.  Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells.

Authors:  Selami Demirci; Ayşegül Doğan; Hüseyin Apdik; Emre Can Tuysuz; Sukru Gulluoglu; Omer Faruk Bayrak; Fikrettin Şahin
Journal:  Mol Cell Biochem       Date:  2017-06-15       Impact factor: 3.396

Review 3.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

4.  PFK15, a PFKFB3 antagonist, inhibits autophagy and proliferation in rhabdomyosarcoma cells.

Authors:  Chunhui Wang; Jianghong Qu; Siyuan Yan; Quan Gao; Sibin Hao; Dongsheng Zhou
Journal:  Int J Mol Med       Date:  2018-03-29       Impact factor: 4.101

5.  MCT1 regulates aggressive and metabolic phenotypes in bladder cancer.

Authors:  Guiming Zhang; Yongjian Zhang; Dahai Dong; Fangming Wang; Xiaocheng Ma; Fengju Guan; Lijiang Sun
Journal:  J Cancer       Date:  2018-06-15       Impact factor: 4.207

6.  Monocarboxylate transporter 1 and monocarboxylate transporter 4 in cancer-endothelial co-culturing microenvironments promote proliferation, migration, and invasion of renal cancer cells.

Authors:  Chen Guo; Tao Huang; Qing-Hai Wang; Hong Li; Aashish Khanal; En-Hao Kang; Wei Zhang; Hai-Tao Niu; Zhen Dong; Yan-Wei Cao
Journal:  Cancer Cell Int       Date:  2019-06-28       Impact factor: 5.722

Review 7.  Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy.

Authors:  Mathijs P Scholtes; Florus C de Jong; Tahlita C M Zuiverloon; Dan Theodorescu
Journal:  Cancers (Basel)       Date:  2021-01-14       Impact factor: 6.639

8.  In Vivo Anticancer Activity of AZD3965: A Systematic Review.

Authors:  Ana Silva; Beatriz Antunes; Alberta Batista; Filipa Pinto-Ribeiro; Fátima Baltazar; Julieta Afonso
Journal:  Molecules       Date:  2021-12-29       Impact factor: 4.411

9.  Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer.

Authors:  Yang Zhao; Bin Zhao; Wei-Hua Yan; Yan Xia; Zhi-Hui Wang; Guo-Yang Zheng; Wen-Da Wang; Yu-Shi Zhang
Journal:  Front Oncol       Date:  2021-08-26       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.